Stem Cell Transplant

Over the last two decades, the University of Chicago Medicine has assumed a leadership role in advancing the successful use of stem cell transplants for people with leukemia, lymphoma, and other cancers and blood diseases. Our physicians were among the first to perform unrelated donor transplants.

Wendy Stock, MD, and Anjuli Nayak, MD
When Anjuli Nayak, MD, right, was diagnosed with acute lymphoblastic leukemia (ALL), she received a tailored treatment plan recommended by Wendy Stock, MD, left, that included enrolling in a clinical trial involving transplantation of stem cells from both a half-match donor and from donated umbilical cord stem cells. » Read Nayak's story

Today, we continue to offer the latest promising approaches in stem cell transplants, including multiple cord blood transplants for adults and modified conditioning transplants that minimize side effects and generally allow excellent quality of life.

For all the medical breakthroughs available here, our program has a personal "feel." We put a priority on the relationships between clinicians and patients. All patients are assigned a primary transplant physician -- who is also a hematologists/oncologist -- and a dedicated nurse coordinator who follows them before, during, and after their transplant. We feel these close, one-on-one relationships are vital with a treatment like stem cell transplant, which involves such a major commitment on the part of patients and their families.


Video

Dr. Lucy Godley on Stem Cell Transplant

Lucy Godley, MD, PhD, assistant professor of medicine at the medical center, talks about what stem cell transplants are like for the patient receiving the transplant, potential complications associated with the procedure, and the long-term prognosis after transplant.
» View more videos about stem cell transplantation

Clinical Trials